相关实验视频
Updated: Jul 26, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
伊克萨佐米布诱导的斯威特综合征:一个病例报告
Jeanne Bellemare1, Hannah Laure El Fassy2, Alexandra Mereniuk1
1Division of Dermatology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, QC, Canada.
SAGE open medical case reports
|June 21, 2023
概括
艾克萨佐米布是一种蛋白酶体抑制剂,在多发性骨髓瘤患者中很少会引起甜心综合征. 这一案例突出了用皮质类固醇成功管理的情况,允许继续治疗癌症.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 伊克萨佐米布是一种用于多发性骨髓瘤的蛋白酶体抑制剂.
- 斯威特综合征是一种不常见的药物不良反应.
研究的目的:
- 报告一种罕见的药物诱导的Sweet综合征病例,这种病症是由ixazomib引起的.
- 描述这种不良事件的成功管理.
主要方法:
- 一名患有耐火性多发性骨髓瘤的62岁男性患者接受了ixazomib的治疗.
- 患者出现了与Sweet综合征相一致的症状.
- 使用ixazomib的挑战证实了药物诱导的病因.
- 治疗涉及皮质类固醇和延续艾克萨佐米布治疗.
主要成果:
- 患者经历了复发的甜蜜综合征在ixazomib重新挑战后.
- 添加每周一次的皮质类固醇导致症状消失.
- 患者能够恢复因多发性骨髓瘤而接受的ixazomib治疗.
结论:
- 伊克萨佐米布是一种罕见但可能导致药物诱导的斯威特综合征的原因.
- 皮质类固醇可以有效地管理依克萨佐米布诱导的斯威特综合征.
- 管理允许继续基本的多发性骨髓瘤治疗.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
252
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
252
Conditioned Taste Aversion
190
Conditioned taste aversion, also known as sauce béarnaise syndrome, is a phenomenon in which an individual develops an aversion to a certain food taste following a negative experience, typically illness. This form of aversion is a type of classical conditioning in which the taste of the food (conditioned stimulus, CS) is associated with the experience of illness (unconditioned stimulus, UCS).
A notable characteristic of conditioned taste aversion is that it often requires only a single...
A notable characteristic of conditioned taste aversion is that it often requires only a single...
190
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
209
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
209
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
356
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
356
SBAR II: Application of SBAR
4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240

